Click for best price
Type1 Diabetes Treatment Market Size, Share 2024
| Market size in 2023 |
US$ 4734.8 million
|
Forecast Market size by 2030 |
US$ 6725.8 million
|
| Growth Rate |
CAGR of 4.7% |
Number of Pages |
103 Pages |
The global Type-1 Diabetes Treatment market was valued at US$ 4734.8 million in 2023 and is projected to reach US$ 6725.8 million by 2030, at a CAGR of 4.7% during the forecast period.
This research report provides a comprehensive analysis of the Type-1 Diabetes Treatment market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Type-1 Diabetes Treatment market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Type-1 Diabetes Treatment, challenges faced by the industry, and potential opportunities for market players.
The global Type-1 Diabetes Treatment market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Type-1 Diabetes Treatment market presents opportunities for various stakeholders, including Hospitals & Clinics, Academic & Research Institutes. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Type-1 Diabetes Treatment market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Type-1 Diabetes Treatment market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Type-1 Diabetes Treatment market.
Market Overview: The report provides a comprehensive overview of the Type-1 Diabetes Treatment market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Rapid-Acting Insulin, Short-Acting Insulin), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Type-1 Diabetes Treatment market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Type-1 Diabetes Treatment market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Type-1 Diabetes Treatment market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Type-1 Diabetes Treatment market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Type-1 Diabetes Treatment market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Type-1 Diabetes Treatment market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Type-1 Diabetes Treatment, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Type-1 Diabetes Treatment market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Type-1 Diabetes Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Rapid-Acting Insulin
- Short-Acting Insulin
- Others
Market segment by Application
- Hospitals & Clinics
- Academic & Research Institutes
Global Type-1 Diabetes Treatment Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Astellas Pharma
- Merck
- Eli Lilly
- Novo Nordisk
- Sanofi
- AstraZeneca
- Boehringer Ingelheim GmbH
- Novartis
- Pfizer Inc.
- Abbott Laboratories
- Mannkind Corporation
- Braun Melsungen AG
- Macrogenics, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Type-1 Diabetes Treatment, market overview.
Chapter 2: Global Type-1 Diabetes Treatment market size in revenue.
Chapter 3: Detailed analysis of Type-1 Diabetes Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Type-1 Diabetes Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Type-1 Diabetes Treatment Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 4734.8 million
|
| Forecast Market size by 2030 |
US$ 6725.8 million
|
| Growth Rate |
CAGR of 4.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
103 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Type-1 Diabetes Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Type-1 Diabetes Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Type-1 Diabetes Treatment Overall Market Size
2.1 Global Type-1 Diabetes Treatment Market Size: 2023 VS 2030
2.2 Global Type-1 Diabetes Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Type-1 Diabetes Treatment Players in Global Market
3.2 Top Global Type-1 Diabetes Treatment Companies Ranked by Revenue
3.3 Global Type-1 Diabetes Treatment Revenue by Companies
3.4 Top 3 and Top 5 Type-1 Diabetes Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Type-1 Diabetes Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Type-1 Diabetes Treatment Players in Global Market
3.6.1 List of Global Tier 1 Type-1 Diabetes Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Type-1 Diabetes Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Type-1 Diabetes Treatment Market Size Markets, 2023 & 2030
4.1.2 Rapid-Acting Insulin
4.1.3 Short-Acting Insulin
4.1.4 Others
4.2 By Type - Global Type-1 Diabetes Treatment Revenue & Forecasts
4.2.1 By Type - Global Type-1 Diabetes Treatment Revenue, 2019-2024
4.2.2 By Type - Global Type-1 Diabetes Treatment Revenue, 2025-2030
4.2.3 By Type - Global Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Type-1 Diabetes Treatment Market Size, 2023 & 2030
5.1.2 Hospitals & Clinics
5.1.3 Academic & Research Institutes
5.2 By Application - Global Type-1 Diabetes Treatment Revenue & Forecasts
5.2.1 By Application - Global Type-1 Diabetes Treatment Revenue, 2019-2024
5.2.2 By Application - Global Type-1 Diabetes Treatment Revenue, 2025-2030
5.2.3 By Application - Global Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Type-1 Diabetes Treatment Market Size, 2023 & 2030
6.2 By Region - Global Type-1 Diabetes Treatment Revenue & Forecasts
6.2.1 By Region - Global Type-1 Diabetes Treatment Revenue, 2019-2024
6.2.2 By Region - Global Type-1 Diabetes Treatment Revenue, 2025-2030
6.2.3 By Region - Global Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Type-1 Diabetes Treatment Revenue, 2019-2030
6.3.2 US Type-1 Diabetes Treatment Market Size, 2019-2030
6.3.3 Canada Type-1 Diabetes Treatment Market Size, 2019-2030
6.3.4 Mexico Type-1 Diabetes Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Type-1 Diabetes Treatment Revenue, 2019-2030
6.4.2 Germany Type-1 Diabetes Treatment Market Size, 2019-2030
6.4.3 France Type-1 Diabetes Treatment Market Size, 2019-2030
6.4.4 U.K. Type-1 Diabetes Treatment Market Size, 2019-2030
6.4.5 Italy Type-1 Diabetes Treatment Market Size, 2019-2030
6.4.6 Russia Type-1 Diabetes Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Type-1 Diabetes Treatment Market Size, 2019-2030
6.4.8 Benelux Type-1 Diabetes Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Type-1 Diabetes Treatment Revenue, 2019-2030
6.5.2 China Type-1 Diabetes Treatment Market Size, 2019-2030
6.5.3 Japan Type-1 Diabetes Treatment Market Size, 2019-2030
6.5.4 South Korea Type-1 Diabetes Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Type-1 Diabetes Treatment Market Size, 2019-2030
6.5.6 India Type-1 Diabetes Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Type-1 Diabetes Treatment Revenue, 2019-2030
6.6.2 Brazil Type-1 Diabetes Treatment Market Size, 2019-2030
6.6.3 Argentina Type-1 Diabetes Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue, 2019-2030
6.7.2 Turkey Type-1 Diabetes Treatment Market Size, 2019-2030
6.7.3 Israel Type-1 Diabetes Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Type-1 Diabetes Treatment Market Size, 2019-2030
6.7.5 UAE Type-1 Diabetes Treatment Market Size, 2019-2030
7 Type-1 Diabetes Treatment Companies Profiles
7.1 Astellas Pharma
7.1.1 Astellas Pharma Company Summary
7.1.2 Astellas Pharma Business Overview
7.1.3 Astellas Pharma Type-1 Diabetes Treatment Major Product Offerings
7.1.4 Astellas Pharma Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.1.5 Astellas Pharma Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Type-1 Diabetes Treatment Major Product Offerings
7.2.4 Merck Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Type-1 Diabetes Treatment Major Product Offerings
7.3.4 Eli Lilly Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Type-1 Diabetes Treatment Major Product Offerings
7.4.4 Novo Nordisk Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Type-1 Diabetes Treatment Major Product Offerings
7.5.4 Sanofi Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Type-1 Diabetes Treatment Major Product Offerings
7.6.4 AstraZeneca Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Boehringer Ingelheim GmbH
7.7.1 Boehringer Ingelheim GmbH Company Summary
7.7.2 Boehringer Ingelheim GmbH Business Overview
7.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Major Product Offerings
7.7.4 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.7.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Type-1 Diabetes Treatment Major Product Offerings
7.8.4 Novartis Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.8.5 Novartis Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Type-1 Diabetes Treatment Major Product Offerings
7.9.4 Pfizer Inc. Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Company Summary
7.10.2 Abbott Laboratories Business Overview
7.10.3 Abbott Laboratories Type-1 Diabetes Treatment Major Product Offerings
7.10.4 Abbott Laboratories Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.10.5 Abbott Laboratories Key News & Latest Developments
7.11 Mannkind Corporation
7.11.1 Mannkind Corporation Company Summary
7.11.2 Mannkind Corporation Business Overview
7.11.3 Mannkind Corporation Type-1 Diabetes Treatment Major Product Offerings
7.11.4 Mannkind Corporation Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.11.5 Mannkind Corporation Key News & Latest Developments
7.12 Braun Melsungen AG
7.12.1 Braun Melsungen AG Company Summary
7.12.2 Braun Melsungen AG Business Overview
7.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Major Product Offerings
7.12.4 Braun Melsungen AG Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.12.5 Braun Melsungen AG Key News & Latest Developments
7.13 Macrogenics, Inc.
7.13.1 Macrogenics, Inc. Company Summary
7.13.2 Macrogenics, Inc. Business Overview
7.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Major Product Offerings
7.13.4 Macrogenics, Inc. Type-1 Diabetes Treatment Revenue in Global Market (2019-2024)
7.13.5 Macrogenics, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Type-1 Diabetes Treatment Market Opportunities & Trends in Global Market
Table 2. Type-1 Diabetes Treatment Market Drivers in Global Market
Table 3. Type-1 Diabetes Treatment Market Restraints in Global Market
Table 4. Key Players of Type-1 Diabetes Treatment in Global Market
Table 5. Top Type-1 Diabetes Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Type-1 Diabetes Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Type-1 Diabetes Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Type-1 Diabetes Treatment Product Type
Table 9. List of Global Tier 1 Type-1 Diabetes Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Type-1 Diabetes Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Type-1 Diabetes Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Type-1 Diabetes Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Type-1 Diabetes Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Type-1 Diabetes Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Type-1 Diabetes Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Type-1 Diabetes Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Type-1 Diabetes Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Type-1 Diabetes Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Type-1 Diabetes Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Astellas Pharma Company Summary
Table 31. Astellas Pharma Type-1 Diabetes Treatment Product Offerings
Table 32. Astellas Pharma Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Astellas Pharma Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Type-1 Diabetes Treatment Product Offerings
Table 36. Merck Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Merck Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Type-1 Diabetes Treatment Product Offerings
Table 40. Eli Lilly Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. Novo Nordisk Company Summary
Table 43. Novo Nordisk Type-1 Diabetes Treatment Product Offerings
Table 44. Novo Nordisk Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Novo Nordisk Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Type-1 Diabetes Treatment Product Offerings
Table 48. Sanofi Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Sanofi Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Type-1 Diabetes Treatment Product Offerings
Table 52. AstraZeneca Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Boehringer Ingelheim GmbH Company Summary
Table 55. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Offerings
Table 56. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Type-1 Diabetes Treatment Product Offerings
Table 60. Novartis Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Pfizer Inc. Company Summary
Table 63. Pfizer Inc. Type-1 Diabetes Treatment Product Offerings
Table 64. Pfizer Inc. Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Pfizer Inc. Key News & Latest Developments
Table 66. Abbott Laboratories Company Summary
Table 67. Abbott Laboratories Type-1 Diabetes Treatment Product Offerings
Table 68. Abbott Laboratories Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Abbott Laboratories Key News & Latest Developments
Table 70. Mannkind Corporation Company Summary
Table 71. Mannkind Corporation Type-1 Diabetes Treatment Product Offerings
Table 72. Mannkind Corporation Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 73. Mannkind Corporation Key News & Latest Developments
Table 74. Braun Melsungen AG Company Summary
Table 75. Braun Melsungen AG Type-1 Diabetes Treatment Product Offerings
Table 76. Braun Melsungen AG Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 77. Braun Melsungen AG Key News & Latest Developments
Table 78. Macrogenics, Inc. Company Summary
Table 79. Macrogenics, Inc. Type-1 Diabetes Treatment Product Offerings
Table 80. Macrogenics, Inc. Type-1 Diabetes Treatment Revenue (US$, Mn) & (2019-2024)
Table 81. Macrogenics, Inc. Key News & Latest Developments
List of Figures
Figure 1. Type-1 Diabetes Treatment Segment by Type in 2023
Figure 2. Type-1 Diabetes Treatment Segment by Application in 2023
Figure 3. Global Type-1 Diabetes Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Type-1 Diabetes Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Type-1 Diabetes Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2023
Figure 8. By Type - Global Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 16. US Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 28. China Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Type-1 Diabetes Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Astellas Pharma Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Merck Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Eli Lilly Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Novo Nordisk Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Sanofi Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. AstraZeneca Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Novartis Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Pfizer Inc. Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Abbott Laboratories Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Mannkind Corporation Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Braun Melsungen AG Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Macrogenics, Inc. Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
